Fingolimod Capsule bulk supplier for pharma manufacturers

Fingolimod Capsule 0.5 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 0.5 mg

Reference Brands: Gilenya(US)

Fingolimod inhibits sphingosine-1-phosphate receptors, trapping lymphocytes in lymph nodes and preventing their migration to the brain and spinal cord. It reduces relapse rates, slows disease progression, and decreases lesion development in multiple sclerosis. Benefits include improved neurological stability, fewer relapses, and enhanced quality of life for MS patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Fingolimod capsules, marketed as Gilenya, are approved in the US by the FDA and in the EU via EMA for relapsing-remitting multiple sclerosis (RRMS). Regulatory approval requires a comprehensive dossier including clinical trial data, safety, efficacy, manufacturing processes, and pharmacovigilance plans. In the US, FDA review involves detailed evaluation of clinical and quality data, while the EMA ensures regional compliance with safety and manufacturing standards.

Fingolimod Capsule — third party manufacturing & bulk supply

Fingolimod Capsule 0.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fingolimod Capsule is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fingolimod Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fingolimod Capsule →

Back to Listing

Frequently Asked Questions

Fingolimod Capsule is listed as Capsules in 0.5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Fingolimod Capsule is referenced against Gilenya(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.